Related Experiment Video
Updated: Jun 23, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
Erk1/2 MAP kinases are required for epidermal G2/M progression
Phillip A Dumesic1, Florence A Scholl, Deborah I Barragan
1Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA.
Abstract:
Erk1/2 mitogen-activated protein kinases (MAPKs) are often hyperactivated in human cancers, where they affect multiple processes, including proliferation. However, the effects of Erk1/2 loss in normal epithelial tissue, the setting of most extracellular signal-regulated kinase (Erk)-associated neoplasms, are unknown. In epidermis, loss of Erk1 or Erk2 individually has no effect, whereas simultaneous Erk1/2 depletion inhibits cell division, demonstrating that these MAPKs are necessary for normal tissue self-renewal. Growth inhibition caused by Erk1/2 loss is rescued by reintroducing Erk2, but not by activating Erk effectors that promote G1 cell cycle progression. Unlike fibroblasts, in which Erk1/2 loss decreases cyclin D1 expression and induces G1/S arrest, Erk1/2 loss in epithelial cells reduces cyclin B1 and c-Fos expression and induces G2/M arrest while disrupting a gene regulatory network centered on cyclin B1-Cdc2. Thus, the cell cycle stages at which Erk1/2 activity is required vary by cell type, with Erk1/2 functioning in epithelial cells to enable progression through G2/M.
Insights
Extracellular signal-regulated kinase (Erk)1/2 are crucial for normal epithelial tissue renewal. Simultaneous depletion of Erk1/2 inhibits cell division, leading to G2/M arrest, highlighting their essential role in epithelial self-renewal.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Mitogen-activated protein kinases (MAPKs), specifically Erk1/2, are frequently hyperactivated in human cancers.
- The role of Erk1/2 in normal epithelial tissue, where most Erk-associated cancers originate, remains largely unknown.
- Previous studies focused on Erk1/2 function in fibroblasts, revealing distinct cell cycle regulation compared to epithelial cells.
Purpose of the Study:
- To investigate the function of Erk1/2 in normal epithelial tissue self-renewal.
- To determine the specific cell cycle phase regulated by Erk1/2 in epithelial cells.
- To elucidate the molecular mechanisms underlying Erk1/2-dependent cell cycle progression in epidermis.
Main Methods:
- Simultaneous depletion of Erk1 and Erk2 in mouse epidermis using genetic approaches.
- Analysis of cell division, proliferation, and cell cycle progression following Erk1/2 loss.
- Rescue experiments involving reintroduction of Erk2 or activation of downstream effectors.
- Gene expression analysis, focusing on cell cycle regulators like cyclin B1 and c-Fos.
Main Results:
- Individual loss of Erk1 or Erk2 had no discernible effect on epidermal tissue.
- Simultaneous depletion of Erk1/2 significantly inhibited cell division and tissue self-renewal.
- Growth inhibition was rescued by Erk2 reintroduction but not by activating G1 progression effectors.
- Erk1/2 loss in epithelial cells led to reduced cyclin B1 and c-Fos expression, causing G2/M arrest.
- A disruption of the cyclin B1-Cdc2 gene regulatory network was observed.
Conclusions:
- Erk1/2 are essential for the self-renewal of normal epithelial tissues.
- Unlike fibroblasts, Erk1/2 in epithelial cells are required for progression through the G2/M phase of the cell cycle.
- Erk1/2 signaling plays a critical role in maintaining epithelial tissue homeostasis by regulating the G2/M transition.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle
Inhibition of Cdk Activity
Positive Regulator Molecules

